Nurexone Biologic Inc (NRXBF)

$0.50 -0.02 (-3.97%)
Market Cap 41.50M
Revenue (ttm) 0.00
Net Income (ttm) -5.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol 15,276
Day's Range N/A - N/A
Shares Out 80.01M
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target $3.50

Company Profile

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well...

Industry: Biotechnology
Sector: Healthcare
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
FRCresearch
FRCresearch Jul. 21 at 11:15 PM
$NRXBF Disseminated on behalf of NurExone Biologic Inc. (TSXV: NRX / OTCQB: NRXBF / FSE: J90). Update: @NBiologic’s ExoPTEN showed strong preclinical results, improving motor function in spinal cord injury models. Read our analyst note on NurExone’s ExoPTEN preclinical success: https://www.researchfrc.com/content/analyst-ideas/post/302/top-picks-snapshot-tech-mining-movers
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 10 at 5:37 PM
$NRXBF: Test Results Show Spinal Injury Recovery https://pdfhost.io/v/eKEMku7LuY_NRXBF-_Test_Results_Show_Spinal_Injury_Recovery
0 · Reply
ZacksSCR
ZacksSCR Jul. 9 at 8:38 PM
$NRXBF Treatment Restores Mobility to Spinal Injury Patients https://buff.ly/WG5yt3m
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 9 at 5:18 PM
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model $NRXBF https://www.globenewswire.com/news-release/2025/07/08/3112213/0/en/New-ExoPTEN-Preclinical-Study-Indicates-Significant-Improvement-in-Walking-Quality-in-Spinal-Cord-Injury-Model.html
0 · Reply
Northern_Lightz
Northern_Lightz Jun. 20 at 12:29 PM
NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update $NRXBF https://www.globenewswire.com/news-release/2025/06/20/3102535/0/en/NurExone-Advances-U-S-Growth-Strategy-with-Acceptance-into-Prestigious-ARMI-HealthTech-Hub-Accelerator-and-Provides-Corporate-Update.html
0 · Reply
Mark_Venture
Mark_Venture Jun. 7 at 1:51 AM
$NGENF So, for anyone curious about what research is happening for COMPLETE SCI, $NRXBF is the only one I know of that's making progress in that area, so I've bought 3k shares of it for now. I'm thinking NurExone, followed up with NervGen's treatment might be the way complete SCI can be repaired.
1 · Reply
Mark_Venture
Mark_Venture Jun. 7 at 1:44 AM
$NRXBF I'm thinking NurExone to start the repair of complete SCI, followed by $NGENF to continue it.
1 · Reply
ZacksSCR
ZacksSCR Jun. 2 at 2:32 PM
$NRXBF Makes Significant Announcement https://buff.ly/Hg5xmqI
0 · Reply
ZacksSCR
ZacksSCR May. 27 at 5:26 PM
$NRXBF In Great Position for Exciting Year https://buff.ly/otDPjvG
0 · Reply
Northern_Lightz
Northern_Lightz May. 2 at 2:11 PM
NurExone Biologic : A Biotech Stock Turning Heads in 2025 $NRXBF https://10xalerts.com/nurexone-biologic-nrx-a-biotech-stock-turning-heads-in-2025/
0 · Reply
Latest News on NRXBF
No data available.
FRCresearch
FRCresearch Jul. 21 at 11:15 PM
$NRXBF Disseminated on behalf of NurExone Biologic Inc. (TSXV: NRX / OTCQB: NRXBF / FSE: J90). Update: @NBiologic’s ExoPTEN showed strong preclinical results, improving motor function in spinal cord injury models. Read our analyst note on NurExone’s ExoPTEN preclinical success: https://www.researchfrc.com/content/analyst-ideas/post/302/top-picks-snapshot-tech-mining-movers
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 10 at 5:37 PM
$NRXBF: Test Results Show Spinal Injury Recovery https://pdfhost.io/v/eKEMku7LuY_NRXBF-_Test_Results_Show_Spinal_Injury_Recovery
0 · Reply
ZacksSCR
ZacksSCR Jul. 9 at 8:38 PM
$NRXBF Treatment Restores Mobility to Spinal Injury Patients https://buff.ly/WG5yt3m
0 · Reply
Northern_Lightz
Northern_Lightz Jul. 9 at 5:18 PM
New ExoPTEN Preclinical Study Indicates Significant Improvement in Walking Quality in Spinal Cord Injury Model $NRXBF https://www.globenewswire.com/news-release/2025/07/08/3112213/0/en/New-ExoPTEN-Preclinical-Study-Indicates-Significant-Improvement-in-Walking-Quality-in-Spinal-Cord-Injury-Model.html
0 · Reply
Northern_Lightz
Northern_Lightz Jun. 20 at 12:29 PM
NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update $NRXBF https://www.globenewswire.com/news-release/2025/06/20/3102535/0/en/NurExone-Advances-U-S-Growth-Strategy-with-Acceptance-into-Prestigious-ARMI-HealthTech-Hub-Accelerator-and-Provides-Corporate-Update.html
0 · Reply
Mark_Venture
Mark_Venture Jun. 7 at 1:51 AM
$NGENF So, for anyone curious about what research is happening for COMPLETE SCI, $NRXBF is the only one I know of that's making progress in that area, so I've bought 3k shares of it for now. I'm thinking NurExone, followed up with NervGen's treatment might be the way complete SCI can be repaired.
1 · Reply
Mark_Venture
Mark_Venture Jun. 7 at 1:44 AM
$NRXBF I'm thinking NurExone to start the repair of complete SCI, followed by $NGENF to continue it.
1 · Reply
ZacksSCR
ZacksSCR Jun. 2 at 2:32 PM
$NRXBF Makes Significant Announcement https://buff.ly/Hg5xmqI
0 · Reply
ZacksSCR
ZacksSCR May. 27 at 5:26 PM
$NRXBF In Great Position for Exciting Year https://buff.ly/otDPjvG
0 · Reply
Northern_Lightz
Northern_Lightz May. 2 at 2:11 PM
NurExone Biologic : A Biotech Stock Turning Heads in 2025 $NRXBF https://10xalerts.com/nurexone-biologic-nrx-a-biotech-stock-turning-heads-in-2025/
0 · Reply
Northern_Lightz
Northern_Lightz Apr. 23 at 12:44 PM
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario $NRXBF https://www.globenewswire.com/news-release/2025/04/22/3065890/0/en/NurExone-Appoints-Biotech-Industry-Leader-Jacob-Licht-to-Lead-U-S-Operations-and-Exo-Top-Manufacturing-Expansion-and-Completes-Continuance-into-Ontario.html
0 · Reply
ZacksSCR
ZacksSCR Apr. 10 at 3:13 PM
$NRXBF Enters Crucial Stage in Good Shape https://buff.ly/J0IB2Ic
0 · Reply
Northern_Lightz
Northern_Lightz Apr. 10 at 12:43 PM
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update $NRXBF https://www.globenewswire.com/news-release/2025/04/09/3058922/0/en/NurExone-Biologic-Inc-Announces-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
0 · Reply
Northern_Lightz
Northern_Lightz Apr. 7 at 11:10 AM
NurExone Biologic $NRXBF Announces U.S. Uplisting Intention and Closes C$2.3 Million Private Placement https://www.globenewswire.com/news-release/2025/04/04/3055978/0/en/NurExone-Biologic-Announces-U-S-Uplisting-Intention-and-Closes-C-2-3-Million-Private-Placement.html
0 · Reply
Northern_Lightz
Northern_Lightz Mar. 21 at 4:33 PM
NurExone Biologic : A standout performer in the microcap biotech space $NRXBF https://pdfhost.io/v/7TgpDsJepN_NurExone_Biologic_Inc__-_Tormont50_Research_Report_-__NRX_V__March_19_2025
0 · Reply
ZacksSCR
ZacksSCR Mar. 17 at 2:49 PM
$NRXBF $NRX.TSX Test Results Bolster Prospects buff.ly/gpapBZ6
0 · Reply
newsfile_corp
newsfile_corp Mar. 10 at 1:01 PM
https://nfne.ws/241616 $NRXBF $NRX.TSXV @TMXGroup #TSX50 #Banking #FinancialServices #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investin
0 · Reply
Northern_Lightz
Northern_Lightz Feb. 28 at 12:13 PM
NurExone Biologic to Present at MIXiii 2025; Professor Michael Belkin, Head of NurExone Ophthalmology Project, to Receive Lifetime Achievement Award $NRXBF https://www.globenewswire.com/news-release/2025/2/27/3034282/0/en/NurExone-Biologic-to-Present-at-MIXiii-2025-Professor-Michael-Belkin-Head-of-NurExone-Ophthalmology-Project-to-Receive-Lifetime-Achievement-Award.html
0 · Reply
Northern_Lightz
Northern_Lightz Feb. 20 at 3:17 PM
NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock $NRXBF https://www.globenewswire.com/news-release/2025/02/19/3029136/0/en/NurExone-Biologic-Recognized-as-a-2025-TSX-Venture-50-Top-Performing-Stock.html
0 · Reply
Northern_Lightz
Northern_Lightz Feb. 18 at 2:01 PM
NurExone Biologic $NRXBF Continues Expansion of U.S. Presence and Awareness with Prestigious Conference Presentation https://www.globenewswire.com/news-release/2025/02/14/3026870/0/en/NurExone-Biologic-Continues-Expansion-of-U-S-Presence-and-Awareness-with-Prestigious-Conference-Presentation.html
0 · Reply
Fred1001
Fred1001 Jan. 31 at 10:06 AM
$NRXBF Linkedin CEO Lior Shaltiel, PhD : A huge hats off 🎩👏 to NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) Scientific Advisory Board (SAB) member, Prof. Michael Belkin, who will be receiving the Visionary Award at the prestigious Glaucoma 360 conference in San Francisco! His groundbreaking innovations have helped shape the future of eye care. We are honored that such a visionary and respected leader participated in the latest Nurexone funding round and leading the company's activities in the Glaucoma field - We appreciate his confidence in our mission, team and what lies ahead. More exciting updates to come as we expand our activity in the U.S! Source: https://www.linkedin.com/search/results/all/?fetchDeterministicClustersOnly=true&heroEntityKey=urn%3Ali%3Afsd_profile%3AACoAAAsQe1YBuq9KmFcBfnLXsxwHrFR7msJphgU&keywords=lior%20shaltiel%2C%20phd&origin=RICH_QUERY_SUGGESTION&position=0&searchId=bba171c7-b4df-4f00-b8e2-5f693683f94c&sid=.0C&spellCorrectionEnabled=false
0 · Reply
Northern_Lightz
Northern_Lightz Jan. 21 at 3:06 PM
The Regenerative Medicine Revolution: A Glimpse into 2025 $NRXBF https://10xalerts.com/the-regenerative-medicine-revolution-a-glimpse-into-2025/
0 · Reply